Are Engineered Small Proteins the Next-generation Immune Checkpoint Inhibitors?
The inaugural International Cancer Immunotherapy Conference, hosted jointly by the Cancer Research Institute (CRI), the Association for Cancer Immunotherapy...
The inaugural International Cancer Immunotherapy Conference, hosted jointly by the Cancer Research Institute (CRI), the Association for Cancer Immunotherapy...
China, a nation of 1.3 billion people, is facing an ongoing cancer epidemic, with more than 3 million people...
Every year, the American Association for Cancer Research (AACR) organizes a robust program of educational workshops for early-career investigators...
In recognition of June as Cancer Immunotherapy Month, organized by our colleagues at the Cancer Research Institute (CRI), the...
Conference co-chair Elaine R. Mardis, PhD, discusses the third conference in the AACR's Precision Medicine Series, “Integrating Clinical Genomics...
May is Brain Cancer Awareness Month, and this week, the sharpest minds in brain cancer research will convene in...
This year, at the AACR Annual Meeting held in Philadelphia April 18 to 22, an astounding 19,300 members of...
During the American Association for Cancer Research Annual Meeting held last month in Philadelphia, 30 patient advocates—many of them...
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...
Game-changing modern cancer therapies—immunotherapies and targeted therapies, among others—have been providing promising treatment outcomes in the recent years. The...